Search results
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
Digital Journal· 2 days agoAlthough the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, ...
Veru to Present at the Jefferies Global Healthcare Conference
Morningstar· 3 days agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoEngineering the Future: Gene Synthesis Market's Phenomenal Growth Forecast 15.8% CAGR PR Newswire BOSTON, May 23, 2024 Global Gene Synthesis Market to Reach $4.1 Billion by 2028, Driven by Technological Advancements and Increased Research Activities
Here's Why You Should Retain Walgreens Boots (WBA) For Now
Zacks· 2 days agoFree Report) is well poised to grow in the coming quarters, backed by its recent product launches. The company continues to progress in cost-cutting initiatives. In the past year, the Zacks ...
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks· 3 days agoFree Report) announced that the FDA will now decide on the biologics license application (BLA) for the subcutaneous formulation of Opdivo (nivolumab) on Dec 29, 2024. The subcutaneous formulation ...
Lexaria Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy
Digital Journal· 3 days agoFactors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and ...
Corporate boards have never been more prepared to face down the anti-ESG backlash, new research...
Fortune· 4 days agoIn the past, corporate boards were not much involved in these issues. In 2018, for example, when NYU Stern Center for Sustainable Business (CSB) first assessed sustainability on Fortune 100 ...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance
KTLA-TV Los Angeles· 2 days agoIndivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation of the expected primary listing of the Company's shares on Nasdaq , members of Indivior's ...